ISTH0036
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for ISTH0036, covering 2018-02-28 to 2018-02-28. Get the full timeline:
Most recent: Clinical Trial Update: Phase I Dose Escalation Study to Investigate the Safety of ISTH0036 in Subjects With Glaucoma Undergoing Trabeculectomy [Phase 1]